Merck quarterly profit falls on deal-related charge

Reuters

Published Oct 29, 2019 11:04

Merck quarterly profit falls on deal-related charge

(Reuters) - Drugmaker Merck & Co Inc (N:MRK) reported a drop in third-quarter profit on Tuesday, hit by a $982 million charge related to its acquisition of Peloton (NASDAQ:PTON) Therapeutics.

Net income fell to $1.90 billion (£1.48 billion), or 74 cents per share, from $1.95 billion, or 73 cents per share, a year earlier.